Results 91 to 100 of about 9,892 (240)

Relation of serum magnesium levels and postdischarge outcomes in patients hospitalized for heart failure (from the EVEREST Trial) [PDF]

, 2013
Serum magnesium levels may be impacted by neurohormonal activation, renal function, and diuretics. The clinical profile and prognostic significance of serum magnesium level concentration in patients hospitalized for heart failure (HF) with reduced ...
Ambrosy, Andrew P, Butler, Javed, Fonarow, Gregg C, Gheorghiade, Mihai, Greene, Stephen J, Investigators, EVEREST Trial, Konstam, Marvin A, Maggioni, Aldo P, Mentz, Robert J, Nodari, Savina, Subacius, Haris P, Vaduganathan, Muthiah, Zannad, Faiez   +12 more
core   +1 more source

Clinical effect of long-term administration of tolvaptan in patients with heart failure and chronic kidney disease [PDF]

, 2019
学位記番号 ...
Ono, Yohei, オノ, ヨウヘイ, 小野, 洋平   +2 more
core  

Tolvaptan or transplant: why wait? [PDF]

, 2020
Craig E. Gordon, Ronald D. Perrone
openalex   +1 more source

Short term efficacy and safety of low dose tolvaptan in patients with acute decompensated heart failure with hyponatremia: a prospective observational pilot study from a single center in South India

Heart Views, 2014
Background: In acute decompensated heart failure (ADHF), diuretic use, the mainstay therapy for congestion, is associated with electrolyte abnormalities and worsening renal function. Vasopressin mediates fluid retention in heart failure.
Soumya Patra, Basant Kumar, Kaushal K Harlalka, Apoorva Jain, H M Bhanuprakash, K S Sadananda, Harsha Basappa, K Santhosh, K S Rajith, K S Bharathi, C N Manjunath   +10 more
doaj   +1 more source

Autosomal-dominante polyzystische Nierenerkrankung: Neue therapeutische Ansätze [PDF]

, 2018
Zusammenfassung: Die autosomal-dominante polyzystische Nierenerkrankung ("autosomal dominant polycystic kidney disease", ADPKD) ist die häufigste genetische Nierenerkrankung, sie betrifft weltweit etwa 6Mio. Menschen.
Poster, D., Serra, A.L., Wüthrich, R.P.
core  

Inhibition of cyst growth in PCK and Wpk rat models of polycystic kidney disease with low doses of peroxisome proliferator-activated receptor γ agonists [PDF]

, 2016
Background and Objectives The studies were designed to test the efficacy of two peroxisome proliferator-activated receptor γ (PPARγ) agonists in two rodent models of polycystic kidney disease (PKD).
Blazer-Yost, Bonnie L., Flaig, Stephanie M., Gattone, Vincent H.   +2 more
core   +1 more source

An Empirical Biomarker-based Calculator for Autosomal Recessive Polycystic Kidney Disease - The Nieto-Narayan Formula

, 2016
Autosomal polycystic kidney disease (ARPKD) is associated with progressive enlargement of the kidneys fuelled by the formation and expansion of fluid-filled cysts.
Goldberg, Itzhak D., Narayan, Prakash, Nieto, Jake A., Yamin, Michael A.   +3 more
core   +2 more sources

Heart rate and blood pressure monitoring in heart failure. [PDF]

, 2019
It has been long known that incessant tachycardia and severe hypertension can cause heart failure (HF). In recent years, it has also been recognized that more modest elevations in either heart rate (HR) or blood pressure (BP), if sustained, can be a risk
Coats, AJS, Piepoli, MF, Ponikowski, P, Rosano, GMC, Spoletini, I   +4 more
core   +1 more source

Ascites of patients with solid tumors shows distinct inflammatory patterns

Cancer Communications, Volume 45, Issue 8, Page 936-940, August 2025.
Julia M. Berger, Martin Korpan, Carina Zierfuss, Katharina Syböck, Erwin Tomasich, Andreas Kienzle, Maria Koenig, Markus Kleinberger, Lynn Gottmann, Birgit Fendl, Cihan Ay, Johannes Pammer, Catharina Müller, Rudolf Oehler, Lorenz Balcar, Thomas Reiberger, Elisabeth S. Bergen, Barbara Niederdorfer, Matthias Preusser, Anna S. Berghoff   +19 more
wiley   +1 more source

Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT‐1 and SALT‐2 trials

Cancer Medicine, 2017
Hyponatremia is a common electrolyte disorder in cancer patients and has been associated with poor prognosis. A frequent cause of cancer‐related hyponatremia is the syndrome of inappropriate antidiuretic hormone (SIADH).
Richard J. Gralla, Fatima Ahmad, Jaime D. Blais, Joseph Chiodo III, Wen Zhou, Linda A. Glaser, Frank S. Czerwiec   +6 more
doaj   +1 more source